Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Whitney Bancroft Pope

Title(s)Professor-in-Residence, Radiological Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A comprehensive clinical, molecular, radiological, and surgical analysis for predicting prognosis in IDH-mutant astrocytoma patients. Neuro Oncol. 2026 May 02. Cho M, Kim M, Kim H, Choi K, Han K, Ahn SS, Yoon HI, Chang JH, Kim SH, Lee SK, Park YW, Pope WB. PMID: 42080952.
      View in: PubMed   Mentions:    Fields:    
    2. 18F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiation Therapy: Image Interpretation Criteria and Diagnostic Performance From the PURSUE Study. Int J Radiat Oncol Biol Phys. 2026 Feb 26. Kotecha R, Chiang V, Tom MC, Parent E, Nabavizadeh A, Siegel BA, Huang J, Zan E, Peddi S, Brem S, Ware M, Sulman EP, Kesari S, Pope W, Holmes R, Chau A, Teoh EJ, Chao ST, Aboian M, PURSUE Study Group. PMID: 41759680.
      View in: PubMed   Mentions:    Fields:    
    3. "Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging. AJNR Am J Neuroradiol. 2025 Feb 03; 46(2):311-320. Sanvito F, Yao J, Cho NS, Raymond C, Telesca D, Pope WB, Everson RG, Salamon N, Boxerman JL, Cloughesy TF, Ellingson BM. PMID: 39242197; PMCID: PMC11878977.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Reply. AJNR Am J Neuroradiol. 2025 Jan 08; 46(1):221-222. Ellingson BM, Sanvito F, Pope WB, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Chang SM, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Wen PY, Vogelbaum MA, van den Bent M. PMID: 39730160; PMCID: PMC11735428.
      View in: PubMed   Mentions:    Fields:    
    5. A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults. AJNR Am J Neuroradiol. 2024 12 09; 45(12):1846-1856. Ellingson BM, Sanvito F, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Pope WB, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Vogelbaum MA, van den Bent M, Chang SM, Wen PY. PMID: 38926092; PMCID: PMC11630866.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    6. Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas. Neuroradiology. 2024 Dec; 66(12):2153-2162. Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Salamon N, Cloughesy TF, Ellingson BM. PMID: 39377927; PMCID: PMC11611930.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction. AJNR Am J Neuroradiol. 2024 02 07; 45(2):188-197. Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Salamon N, Ellingson BM. PMID: 38238098; PMCID: PMC11285991.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    8. Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study. Neuro Oncol. 2023 03 14; 25(3):533-543. Vollmuth P, Foltyn M, Huang RY, Galldiks N, Petersen J, Isensee F, van den Bent MJ, Barkhof F, Park JE, Park YW, Ahn SS, Brugnara G, Meredig H, Jain R, Smits M, Pope WB, Maier-Hein K, Weller M, Wen PY, Wick W, Bendszus M. PMID: 35917833; PMCID: PMC10013635.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    9. Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation. J Neurooncol. 2022 Oct; 160(1):115-125. Shidoh S, Savjani RR, Cho NS, Ullman HE, Hagiwara A, Raymond C, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Kaprealian TB, Salamon N, Ellingson BM. PMID: 36053452; PMCID: PMC9622513.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors. NMR Biomed. 2023 06; 36(6):e4785. Cho NS, Hagiwara A, Yao J, Nathanson DA, Prins RM, Wang C, Raymond C, Desousa BR, Divakaruni A, Morrow DH, Nghiemphu PL, Lai A, Liau LM, Everson RG, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 35704275; PMCID: PMC13030910.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    11. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2022 06 01; 24(6):1020-1028. Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Prins RM, Cloughesy TF, Ellingson BM. PMID: 34865129; PMCID: PMC9159421.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    12. Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation Networks. Tomography. 2022 05 26; 8(3):1437-1452. Wang C, Cho NS, Dyk KV, Islam S, Raymond C, Choi J, Salamon N, Pope WB, Lai A, Cloughesy TF, Nghiemphu PL, Ellingson BM. PMID: 35736864; PMCID: PMC9229761.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study. Cancers (Basel). 2022 May 20; 14(10). Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35626127; PMCID: PMC9139712.
      View in: PubMed   Mentions: 4  
    14. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Front Oncol. 2022; 12:849993. Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. PMID: 35371980; PMCID: PMC8964348.
      View in: PubMed   Mentions: 3  
    15. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI. Sci Rep. 2022 01 20; 12(1):1078. Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35058510; PMCID: PMC8776874.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    16. Radiomics for precision medicine in glioblastoma. J Neurooncol. 2022 Jan; 156(2):217-231. Aftab K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, Rock JP, Enam SA. PMID: 35020109.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    17. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021; 32:102882. Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 34911188; PMCID: PMC8609049.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. Imaging Advances for Central Nervous System Tumors. Hematol Oncol Clin North Am. 2022 02; 36(1):43-61. Huang RY, Pope WB. PMID: 34563433.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Characterization of cognitive function in survivors of diffuse gliomas using resting-state functional MRI (rs-fMRI). Brain Imaging Behav. 2022 Feb; 16(1):239-251. Wang C, Van Dyk K, Cho N, Raymond C, Choi J, Salamon N, Pope WB, Lai A, Cloughesy TF, Nghiemphu PL, Ellingson BM. PMID: 34350525; PMCID: PMC8825610.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    20. Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden. Ann Nucl Med. 2021 Sep; 35(9):1022-1029. Tatekawa H, Uetani H, Hagiwara A, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 34121166.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas. J Neurooncol. 2021 May; 152(3):573-582. Tatekawa H, Uetani H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. PMID: 33704629; PMCID: PMC8221401.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET. Cancer Imaging. 2021 Mar 10; 21(1):27. Tatekawa H, Hagiwara A, Uetani H, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 33691798; PMCID: PMC7944911.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    23. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas. Neuroradiology. 2021 Jun; 63(6):857-868. Oughourlian TC, Yao J, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 33106922; PMCID: PMC8071834.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. 2020 10 15; 87(5):931-938. Patel KS, Everson RG, Yao J, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32365185; PMCID: PMC7566341.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    25. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. J Neurooncol. 2020 Sep; 149(2):337-346. Tatekawa H, Hagiwara A, Uetani H, Yao J, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32929644; PMCID: PMC7682113.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    26. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Sci Rep. 2020 09 09; 10(1):14819. Patel KS, Yao J, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 32908231; PMCID: PMC7481206.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    27. Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy. iScience. 2020 Sep 25; 23(9):101453. Sperry J, Condro MC, Guo L, Braas D, Vanderveer-Harris N, Kim KKO, Pope WB, Divakaruni AS, Lai A, Christofk H, Castro MG, Lowenstein PR, Le Belle JE, Kornblum HI. PMID: 32861192; PMCID: PMC7471621.
      View in: PubMed   Mentions: 58  
    28. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study. Sci Rep. 2020 07 17; 10(1):11922. Yao J, Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32681084; PMCID: PMC7367867.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    29. Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes. J Nucl Med. 2021 03; 62(3):319-325. Tatekawa H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32646876; PMCID: PMC8049346.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    30. The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China. Front Oncol. 2020; 10:852. Shen G, Wang R, Gao B, Zhang Z, Wu G, Pope W. PMID: 32582544; PMCID: PMC7280555.
      View in: PubMed   Mentions: 10  
    31. Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement. J Neurooncol. 2020 May; 147(3):643-652. Cho N, Wang C, Raymond C, Kaprealian T, Ji M, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 32239430; PMCID: PMC7769136.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas. J Neurooncol. 2020 Mar; 147(1):135-145. Oughourlian TC, Yao J, Yao J, Schlossman J, Raymond C, Ji M, Tatekawa H, Salamon N, Pope WB, Czernin J, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 31981013; PMCID: PMC7080591.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression. Neuro Oncol. 2020 01 11; 22(1):17-30. Galldiks N, Kocher M, Ceccon G, Werner JM, Brunn A, Deckert M, Pope WB, Soffietti R, Le Rhun E, Weller M, Tonn JC, Fink GR, Langen KJ. PMID: 31437274; PMCID: PMC6954406.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    34. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro Oncol. 2019 09 06; 21(9):1184-1196. Yao J, Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. PMID: 31066901; PMCID: PMC7594567.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    35. Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus. Neuro Oncol. 2019 07 11; 21(7):837-853. Schiff D, Van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY. PMID: 30753579; PMCID: PMC6620638.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    36. PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro Oncol. 2019 05 06; 21(5):585-595. Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC. PMID: 30615138; PMCID: PMC6502495.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimals
    37. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. J Neurooncol. 2019 May; 142(3):587-595. Yao J, Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 30806888; PMCID: PMC6482078.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    38. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019 02 26; 9(1):2846. Chakhoyan A, Yao J, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. PMID: 30808879; PMCID: PMC6391482.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    39. Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy. J Neuroradiol. 2020 Mar; 47(2):166-173. Förster A, Böhme J, Maros ME, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Wenz F, Groden C, Pope WB, Giordano FA. PMID: 30659892.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    40. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. Neuro Oncol. 2018 10 09; 20(11):1525-1535. Ellingson BM, Abrey LE, Garcia J, Chinot O, Wick W, Saran F, Nishikawa R, Henriksson R, Mason WP, Harris RJ, Leu K, Woodworth DC, Mehta A, Raymond C, Chakhoyan A, Pope WB, Cloughesy TF. PMID: 29897562; PMCID: PMC6178278.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    41. Improving B0 Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography. 2018 Sep; 4(3):123-137. Yao J, Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 30320212; PMCID: PMC6173788.
      View in: PubMed   Mentions: 20     Fields:    
    42. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2018 08 02; 20(9):1240-1250. Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF. PMID: 29660006; PMCID: PMC6071654.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    43. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma. J Neurooncol. 2018 Sep; 139(3):651-659. Chakhoyan A, Woodworth DC, Harris RJ, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29855771; PMCID: PMC6126989.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    44. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol. Eur Radiol. 2018 Nov; 28(11):4882-4889. Young JR, Qiao J, Orosz I, Salamon N, Franke MA, Kim HJ, Pope WB. PMID: 29744642; PMCID: PMC6226378.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Conventional and advanced magnetic resonance imaging in patients with high-grade glioma. Q J Nucl Med Mol Imaging. 2018 Sep; 62(3):239-253. Pope WB, Brandal G. PMID: 29696946; PMCID: PMC6123261.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    46. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol. 2018 Sep; 139(2):399-409. Patel CB, Fazzari E, Chakhoyan A, Yao J, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. PMID: 29679199; PMCID: PMC6092195.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    47. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med. 2018 11; 80(5):1962-1978. Harris RJ, Yao J, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29626359; PMCID: PMC6107417.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    48. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys. 2018 04 01; 100(5):1195-1203. Kong XT, Nguyen NT, Choi YJ, Zhang G, Nguyen HN, Filka E, Green S, Yong WH, Liau LM, Green RM, Kaprealian T, Pope WB, Nghiemphu PL, Cloughesy T, Lassman A, Lai A. PMID: 29722661; PMCID: PMC6277207.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    49. Brain metastases: neuroimaging. Handb Clin Neurol. 2018; 149:89-112. Pope WB. PMID: 29307364; PMCID: PMC6118134.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    50. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration. Clin Radiol. 2018 03; 73(3):290-295. Young JR, Orosz I, Franke MA, Kim HJ, Woodworth D, Ellingson BM, Salamon N, Pope WB. PMID: 29208312.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    51. Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas. Eur J Radiol. 2017 Dec; 97:31-36. Qiao XJ, Kim HG, Wang DJJ, Salamon N, Linetsky M, Sepahdari A, Ellingson BM, Pope WB. PMID: 29153364; PMCID: PMC6165628.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    52. Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials. Clin Cancer Res. 2017 Oct 01; 23(19):5745-5756. Ellingson BM, Gerstner ER, Smits M, Huang RY, Colen R, Abrey LE, Aftab DT, Schwab GM, Hessel C, Harris RJ, Chakhoyan A, Gahrmann R, Pope WB, Leu K, Raymond C, Woodworth DC, de Groot J, Wen PY, Batchelor TT, van den Bent MJ, Cloughesy TF. PMID: 28655794; PMCID: PMC5626594.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    53. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma. Am J Clin Oncol. 2017 Jun; 40(3):228-234. Boxerman JL, Ellingson BM, Jeyapalan S, Elinzano H, Harris RJ, Rogg JM, Pope WB, Safran H. PMID: 25436828.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    54. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. J Neurooncol. 2017 Aug; 134(1):177-188. Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM. PMID: 28547590; PMCID: PMC7927357.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    55. Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017 Sep; 134(3):495-504. Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. PMID: 28382534; PMCID: PMC7893814.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansPHPublic Health
    56. Evaluation of Magnetonanoparticles Conjugated with New Angiogenesis Peptides in Intracranial Glioma Tumors by MRI. Appl Biochem Biotechnol. 2017 Sep; 183(1):265-279. de Oliveira EA, Lazovic J, Guo L, Soto H, Faintuch BL, Akhtari M, Pope W. PMID: 28281182.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    57. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Neuroimage Clin. 2017; 13:386-394. Galldiks N, Law I, Pope WB, Arbizu J, Langen KJ. PMID: 28116231; PMCID: PMC5226808.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    58. Multiple calcifying pseudoneoplasms of the neuraxis (MCAPNON): Distinct entity, CAPNON variant, or old neurocysticercosis? Neuropathology. 2017 Jun; 37(3):233-240. Abdaljaleel M, Mazumder R, Patel CB, Im K, Pope W, Liau LM, Vinters HV, Yong WH. PMID: 27862397.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T. NMR Biomed. 2016 11; 29(11):1563-1576. Harris RJ, Cloughesy TF, Liau LM, Nghiemphu PL, Lai A, Pope WB, Ellingson BM. PMID: 27717216.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    60. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):649-670. Boxerman JL, Shiroishi MS, Ellingson BM, Pope WB. PMID: 27742108.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    61. Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol. 2017 01; 19(1):89-98. Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF. PMID: 27580889; PMCID: PMC5193027.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    62. Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma. Cancer Sci. 2016 Aug; 107(8):1110-6. Hathout L, Ellingson B, Pope W. PMID: 27240229; PMCID: PMC4982585.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    63. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016 09; 18(9):1199-208. Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC. PMID: 27106405; PMCID: PMC4999003.
      View in: PubMed   Mentions: 381     Fields:    Translation:HumansAnimals
    64. Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma. Cancer. 2016 06 01; 122(11):1718-27. Ellingson BM, Nguyen HN, Lai A, Nechifor RE, Zaw O, Pope WB, Yong WH, Nghiemphu PL, Liau LM, Cloughesy TF. PMID: 26998740.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    65. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab. J Magn Reson Imaging. 2016 11; 44(5):1229-1237. Leu K, Boxerman JL, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 26971534.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    66. Neuroimaging. Handb Clin Neurol. 2016; 134:27-50. Pope WB, Djoukhadar I, Jackson A. PMID: 26948347.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    67. Evidence for rCBV as an early response marker following bevacizumab treatment. Neuro Oncol. 2015 Nov; 17(11):1539-40. Pope WB. PMID: 26453577; PMCID: PMC4648311.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015 Nov; 16(15):e534-e542. Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA. PMID: 26545842; PMCID: PMC4638131.
      View in: PubMed   Mentions: 422     Fields:    Translation:Humans
    69. Association between lesion location and language function in adult glioma using voxel-based lesion-symptom mapping. Neuroimage Clin. 2015; 9:617-24. Banerjee P, Leu K, Harris RJ, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB, Bookheimer SY, Ellingson BM. PMID: 26740915; PMCID: PMC4644251.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    70. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab. Clin Cancer Res. 2016 Feb 01; 22(3):575-81. Huang RY, Rahman R, Ballman KV, Felten SJ, Anderson SK, Ellingson BM, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Pope WB, Cloughesy TF, Wen PY. PMID: 26490307.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    71. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma. Neuro Oncol. 2016 Apr; 18(4):467-78. Shiroishi MS, Boxerman JL, Pope WB. PMID: 26364321; PMCID: PMC4799679.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    72. Two cases of rheumatoid meningitis. Neuropathology. 2016 Feb; 36(1):93-102. Magaki S, Chang E, Hammond RR, Yang I, Mackenzie IR, Chou BT, Choi SI, Jen JC, Pope WB, Bell DA, Vinters HV. PMID: 26350538.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    73. Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma. Tomography. 2015 Sep; 1(1):37-43. Chang W, Pope WB, Harris RJ, Hardy AJ, Leu K, Mody RR, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 26740971; PMCID: PMC4698970.
      View in: PubMed   Mentions: 9     Fields:    
    74. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol. 2015 Sep; 17(9):1188-98. Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. PMID: 26250565; PMCID: PMC4588759.
      View in: PubMed   Mentions: 404     Fields:    Translation:Humans
    75. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors? Neuro Oncol. 2015 Nov; 17(11):1434-44. Galldiks N, Langen KJ, Pope WB. PMID: 26130743; PMCID: PMC4648307.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    76. pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI. Neuro Oncol. 2015 Nov; 17(11):1514-24. Harris RJ, Cloughesy TF, Liau LM, Prins RM, Antonios JP, Li D, Yong WH, Pope WB, Lai A, Nghiemphu PL, Ellingson BM. PMID: 26113557; PMCID: PMC4648305.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimals
    77. Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma. CNS Oncol. 2015; 4(4):247-56. Hathout L, Pope WB, Lai A, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 26095141; PMCID: PMC4538925.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    78. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas. Mol Imaging Biol. 2015 Jun; 17(3):434-42. Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM, Chen W, Czernin J, Cloughesy TF, Ellingson BM. PMID: 25465392.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    79. Patient-specific characterization of the invasiveness and proliferation of low-grade gliomas using serial MR imaging and a mathematical model of tumor growth. Oncol Rep. 2015 Jun; 33(6):2883-8. Hathout L, Ellingson BM, Cloughesy TF, Pope WB. PMID: 25962999.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Predictive imaging marker of bevacizumab efficacy: perfusion MRI. Neuro Oncol. 2015 Aug; 17(8):1046-7. Pope WB. PMID: 25910842; PMCID: PMC4490878.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    81. Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI. Clin Cancer Res. 2015 Oct 01; 21(19):4373-83. Ellingson BM, Lai A, Nguyen HN, Nghiemphu PL, Pope WB, Cloughesy TF. PMID: 25901082; PMCID: PMC4592379.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    82. MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2015 May; 122(3):497-505. Harris RJ, Cloughesy TF, Hardy AJ, Liau LM, Pope WB, Nghiemphu PL, Lai A, Ellingson BM. PMID: 25773062.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    83. Genomics of brain tumor imaging. Neuroimaging Clin N Am. 2015 Feb; 25(1):105-19. Pope WB. PMID: 25476516.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    84. Arterial spin-labeling perfusion MRI stratifies progression-free survival and correlates with epidermal growth factor receptor status in glioblastoma. AJNR Am J Neuroradiol. 2015 Apr; 36(4):672-7. Qiao XJ, Ellingson BM, Kim HJ, Wang DJ, Salamon N, Linetsky M, Sepahdari AR, Jiang B, Tian JJ, Esswein SR, Cloughesy TF, Lai A, Nghiemphu L, Pope WB. PMID: 25542879; PMCID: PMC7964328.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    85. Facing the future of brain tumor clinical research. Clin Cancer Res. 2014 Nov 15; 20(22):5591-600. Gilbert MR, Armstrong TS, Pope WB, van den Bent MJ, Wen PY. PMID: 25398842.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    86. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab. Cancer Imaging. 2014 Nov 14; 14:31. Leu K, Enzmann DR, Woodworth DC, Harris RJ, Tran AN, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 25608485; PMCID: PMC4331836.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    87. A novel bicompartmental mathematical model of glioblastoma multiforme. Int J Oncol. 2015 Feb; 46(2):825-32. Hathout L, Ellingson BM, Cloughesy T, Pope WB. PMID: 25384756.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    88. Emerging techniques and technologies in brain tumor imaging. Neuro Oncol. 2014 Oct; 16 Suppl 7:vii12-23. Ellingson BM, Bendszus M, Sorensen AG, Pope WB. PMID: 25313234; PMCID: PMC4195527.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    89. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). Neuro Oncol. 2014 Oct; 16 Suppl 7:vii36-47. Wen PY, Cloughesy TF, Ellingson BM, Reardon DA, Fine HA, Abrey L, Ballman K, Bendszuz M, Buckner J, Chang SM, Prados MD, Pope WB, Gregory Sorensen A, van den Bent M, Yung WK. PMID: 25313237; PMCID: PMC4195530.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    90. Nitroxoline induces apoptosis and slows glioma growth in vivo. Neuro Oncol. 2015 Jan; 17(1):53-62. Lazovic J, Guo L, Nakashima J, Mirsadraei L, Yong W, Kim HJ, Ellingson B, Wu H, Pope WB. PMID: 25074541; PMCID: PMC4483047.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    91. Intraoperative mass spectrometry of tumor metabolites. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):10906-7. Pope WB. PMID: 25028494; PMCID: PMC4121782.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res. 2014 Jul 01; 20(13):3550-9. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, Elashoff D, Geist C, Silverman DH, Phelps ME, Chen W. PMID: 24687922; PMCID: PMC4079729.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    93. Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro Oncol. 2014 Jun; 16(6):815-22. Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, Green RM, Wang HJ, Yong WH, Elashoff R, Cloughesy TF, Lai A. PMID: 24627236; PMCID: PMC4022228.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    94. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma. J Neurooncol. 2014 Mar; 117(1):53-65. Avliyakulov NK, Rajavel KS, Le KM, Guo L, Mirsadraei L, Yong WH, Liau LM, Li S, Lai A, Nghiemphu PL, Cloughesy TF, Linetsky M, Haykinson MJ, Pope WB. PMID: 24473683.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    95. Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemotherapy. J Neurooncol. 2014 Feb; 116(3):601-8. Zaw TM, Pope WB, Cloughesy TF, Lai A, Nghiemphu PL, Ellingson BM. PMID: 24395348; PMCID: PMC3955987.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. J Neurooncol. 2014 Jan; 116(2):373-9. Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, Nghiemphu PL, Liau LM, Ellingson BM. PMID: 24234804; PMCID: PMC6763342.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    97. Isolated choroid plexus granulomas: initial presentation of neurosarcoidosis? Can J Neurol Sci. 2014 Jan; 41(1):112-4. Kallen ME, Boon-Unge K, Yong WH, Pope WB, Frazee JG, Vinters HV. PMID: 24384351.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    98. Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma. J Neurooncol. 2014 Feb; 116(3):551-8. Woodworth DC, Pope WB, Liau LM, Kim HJ, Lai A, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 24318915; PMCID: PMC3918907.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    99. Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro Oncol. 2014 Mar; 16(3):414-20. Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 24305712; PMCID: PMC3922511.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    100. Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology. 2014 Apr; 271(1):200-10. Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF. PMID: 24475840; PMCID: PMC4263651.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCTClinical Trials
    101. Ensemble segmentation for GBM brain tumors on MR images using confidence-based averaging. Med Phys. 2013 Sep; 40(9):093502. Huo J, Okada K, van Rikxoort EM, Kim HJ, Alger JR, Pope WB, Goldin JG, Brown MS. PMID: 24007185.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    102. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage Clin. 2013; 3:1-7. Wang DJ, Alger JR, Qiao JX, Gunther M, Pope WB, Saver JL, Salamon N, Liebeskind DS, UCLA Stroke Investigators. PMID: 24159561; PMCID: PMC3791289.
      View in: PubMed   Mentions: 135     Fields:    
    103. Functionalized magnetonanoparticles in visualization of intracranial tumors on MRI. Mol Imaging Biol. 2013 Jun; 15(3):299-306. Akhtari M, Pope W, Mathern G, Moats R, Frew A, Mandelkern M. PMID: 23184607.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    104. Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. Neuro Oncol. 2013 May; 15(5):626-34. Naeini KM, Pope WB, Cloughesy TF, Harris RJ, Lai A, Eskin A, Chowdhury R, Phillips HS, Nghiemphu PL, Behbahanian Y, Ellingson BM. PMID: 23444259; PMCID: PMC3635524.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    105. Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review. Hum Pathol. 2013 Jun; 44(6):1177-83. Wu W, Tanrivermis Sayit A, Vinters HV, Pope W, Mirsadraei L, Said J. PMID: 23356953.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    106. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma. J Neurooncol. 2013 Apr; 112(2):257-66. Harris RJ, Cloughesy TF, Pope WB, Godinez S, Natsuaki Y, Nghiemphu PL, Meyer H, Paul D, Behbahanian Y, Lai A, Ellingson BM. PMID: 23344788; PMCID: PMC3616610.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro Oncol. 2013 Mar; 15(3):370-81. Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, Ormiston L, Ancheta K, Hanna R, Miller P, Piccioni D, Ellingson BM, Buchanan C, Mischel PS, Nghiemphu PL, Green R, Wang HJ, Pope WB, Liau LM, Elashoff RM, Cloughesy TF, Yong WH, Lai A. PMID: 23328811; PMCID: PMC3578486.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    108. Imaging biomarkers for antiangiogenic therapy in malignant gliomas. CNS Oncol. 2013 Jan; 2(1):33-47. Leu K, Pope WB, Cloughesy TF, Lai A, Nghiemphu PL, Chen W, Liau LM, Ellingson BM. PMID: 24570837; PMCID: PMC3932329.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    109. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy. Neuro Oncol. 2013 Mar; 15(3):382-90. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. PMID: 23275575; PMCID: PMC3578489.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    110. Magnetic Resonance Imaging of Glioma in the Era of Antiangiogenic Therapy. PET Clin. 2013 Apr; 8(2):163-82. Khan SN, Linetsky M, Ellingson BM, Pope WB. PMID: 27157946.
      View in: PubMed   Mentions: 2     Fields:    
    111. PET Parametric Response Mapping for Clinical Monitoring and Treatment Response Evaluation in Brain Tumors. PET Clin. 2013 Apr; 8(2):201-17. Ellingson BM, Chen W, Harris RJ, Pope WB, Lai A, Nghiemphu PL, Czernin J, Phelps ME, Cloughesy TF. PMID: 27157948.
      View in: PubMed   Mentions: 3     Fields:    
    112. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro Oncol. 2012 Dec; 14(12):1465-72. Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy TF, Lai A, Pope WB. PMID: 23090985; PMCID: PMC3499014.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    113. 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab. Neuro Oncol. 2012 Aug; 14(8):1079-89. Harris RJ, Cloughesy TF, Pope WB, Nghiemphu PL, Lai A, Zaw T, Czernin J, Phelps ME, Chen W, Ellingson BM. PMID: 22711609; PMCID: PMC3408264.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    114. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors. J Neuroimaging. 2014 Jan-Feb; 24(1):23-30. White CM, Pope WB, Zaw T, Qiao J, Naeini KM, Lai A, Nghiemphu PL, Wang JJ, Cloughesy TF, Ellingson BM. PMID: 22672084.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    115. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol. 2012 07; 108(3):491-8. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Lada P, Prados M, Goldin J, Wen PY, Cloughesy T. PMID: 22426926; PMCID: PMC3997502.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    116. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke. 2012 Apr; 43(4):1018-24. Wang DJ, Alger JR, Qiao JX, Hao Q, Hou S, Fiaz R, Gunther M, Pope WB, Saver JL, Salamon N, Liebeskind DS, UCLA Stroke Investigators. PMID: 22328551; PMCID: PMC3314714.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCTClinical Trials
    117. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. J Magn Reson Imaging. 2012 Jun; 35(6):1472-7. Ellingson BM, Zaw T, Cloughesy TF, Naeini KM, Lalezari S, Mong S, Lai A, Nghiemphu PL, Pope WB. PMID: 22281731.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    118. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2012 Mar; 14(3):333-43. Ellingson BM, Cloughesy TF, Zaw T, Lai A, Nghiemphu PL, Harris R, Lalezari S, Wagle N, Naeini KM, Carrillo J, Liau LM, Pope WB. PMID: 22270220; PMCID: PMC3280805.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    119. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. AJNR Am J Neuroradiol. 2012 Jun; 33(6):1059-64. Pope WB, Mirsadraei L, Lai A, Eskin A, Qiao J, Kim HJ, Ellingson B, Nghiemphu PL, Kharbanda S, Soriano RH, Nelson SF, Yong W, Phillips HS, Cloughesy TF. PMID: 22268080; PMCID: PMC8013245.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    120. Current concepts in brain tumor imaging. Am Soc Clin Oncol Educ Book. 2012; 119-24. Norden AD, Pope WB, Chang SM. PMID: 24451720.
      View in: PubMed   Mentions: 4     Fields:    
    121. 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab. J Nucl Med. 2012 Jan; 53(1):29-36. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DH, Satyamurthy N, Phelps ME, Chen W. PMID: 22159180; PMCID: PMC3424269.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    122. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol. 2011 Dec 01; 29(34):4482-90. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS. PMID: 22025148; PMCID: PMC3236649.
      View in: PubMed   Mentions: 249     Fields:    Translation:HumansCells
    123. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol. 2012 Mar; 107(1):197-205. Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM. PMID: 22015945; PMCID: PMC3650613.
      View in: PubMed   Mentions: 161     Fields:    Translation:Humans
    124. Pineocytoma with diffuse dissemination to the leptomeninges. Rare Tumors. 2011 Oct 21; 3(4):e53. Gomez C, Wu J, Pope W, Vinters H, Desalles A, Selch M. PMID: 22355508; PMCID: PMC3282458.
      View in: PubMed   Mentions: 3  
    125. Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. Neuroimage. 2012 Jan 16; 59(2):908-16. Ellingson BM, Cloughesy TF, Pope WB, Zaw TM, Phillips H, Lalezari S, Nghiemphu PL, Ibrahim H, Naeini KM, Harris RJ, Lai A. PMID: 22001163.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    126. Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Oct; 13(10):1151-61. Ellingson BM, Cloughesy TF, Lai A, Mischel PS, Nghiemphu PL, Lalezari S, Schmainda KM, Pope WB. PMID: 21856685; PMCID: PMC3177656.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    127. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2012 Jan; 106(1):111-9. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Lalezari S, Zaw T, Motevalibashinaeini K, Mischel PS, Pope WB. PMID: 21706273.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    128. Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab. Magn Reson Med. 2012 Jan; 67(1):237-45. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB. PMID: 21702063.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    129. Advances in MRI assessment of gliomas and response to anti-VEGF therapy. Curr Neurol Neurosci Rep. 2011 Jun; 11(3):336-44. Pope WB, Young JR, Ellingson BM. PMID: 21234719; PMCID: PMC3075404.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    130. High order diffusion tensor imaging in human glioblastoma. Acad Radiol. 2011 Aug; 18(8):947-54. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. PMID: 21536466.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    131. Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2011 Oct; 105(1):91-101. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB. PMID: 21442275.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    132. Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol. 2011 May; 32(5):882-9. Pope WB, Lai A, Mehta R, Kim HJ, Qiao J, Young JR, Xue X, Goldin J, Brown MS, Nghiemphu PL, Tran A, Cloughesy TF. PMID: 21330401; PMCID: PMC7965548.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    133. Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Apr; 13(4):401-9. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB. PMID: 21324937; PMCID: PMC3064698.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    134. Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab. Neurology. 2011 Feb 01; 76(5):432-7. Pope WB, Xia Q, Paton VE, Das A, Hambleton J, Kim HJ, Huo J, Brown MS, Goldin J, Cloughesy T. PMID: 21282590.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    135. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol. 2011 Jan 10; 29(2):142-8. Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T. PMID: 21135282; PMCID: PMC3058273.
      View in: PubMed   Mentions: 238     Fields:    Translation:HumansCTClinical Trials
    136. Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab. Pharmgenomics Pers Med. 2010; 3:79-85. Wagle N, Nghiemphu L, Lai A, Pope W, Mischel PS, Cloughesy T. PMID: 23226044; PMCID: PMC3513210.
      View in: PubMed   Mentions: 4  
    137. Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease. J Neurol. 2010 May; 257(5):839-42. Ringman JM, Pope W, Salamon N. PMID: 20047059; PMCID: PMC2864895.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    138. Characterizing brain tumor research: the role of the National Institutes of Health. AJNR Am J Neuroradiol. 2010 Apr; 31(4):605-9. Pope WB, Itagaki MW. PMID: 20007725; PMCID: PMC7964238.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    139. Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. J Neurooncol. 2010 Feb; 96(3):359-67. Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. PMID: 19655089; PMCID: PMC2808508.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    140. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology. 2009 Jul; 252(1):182-9. Pope WB, Kim HJ, Huo J, Alger J, Brown MS, Gjertson D, Sai V, Young JR, Tekchandani L, Cloughesy T, Mischel PS, Lai A, Nghiemphu P, Rahmanuddin S, Goldin J. PMID: 19561256.
      View in: PubMed   Mentions: 192     Fields:    Translation:Humans
    141. Cortical dysplasia with prominent Rosenthal fiber formation in a case of intractable pediatric epilepsy. Hum Pathol. 2009 Aug; 40(8):1200-4. Khanlou N, Mathern GW, Mitchell WG, Salamon N, Pope WB, Yong WH, Vinters HV. PMID: 19427021.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    142. Engagement of fusiform cortex and disengagement of lateral occipital cortex in the acquisition of radiological expertise. Cereb Cortex. 2009 Nov; 19(11):2746-54. Harley EM, Pope WB, Villablanca JP, Mumford J, Suh R, Mazziotta JC, Enzmann D, Engel SA. PMID: 19321653; PMCID: PMC2758686.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    143. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology. 2008 Oct; 249(1):268-77. Pope WB, Chen JH, Dong J, Carlson MR, Perlina A, Cloughesy TF, Liau LM, Mischel PS, Nghiemphu P, Lai A, Nelson SF. PMID: 18796682; PMCID: PMC2798090.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    144. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. Eur J Radiol. 2009 Aug; 71(2):242-8. Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W. PMID: 18511228.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    145. Safety of anticoagulation use and bevacizumab in patients with glioma. Neuro Oncol. 2008 Jun; 10(3):355-60. Nghiemphu PL, Green RM, Pope WB, Lai A, Cloughesy TF. PMID: 18436627; PMCID: PMC2563058.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    146. Time course of imaging changes of GBM during extended bevacizumab treatment. J Neurooncol. 2008 Jul; 88(3):339-47. Ananthnarayan S, Bahng J, Roring J, Nghiemphu P, Lai A, Cloughesy T, Pope WB. PMID: 18389177.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    147. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1372-80. Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. PMID: 18355978.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    148. A methodology to integrate clinical data for the efficient assessment of brain-tumor patients. Inform Health Soc Care. 2008 Mar; 33(1):55-68. Morioka CA, El-Saden S, Pope W, Sayre J, Duckwiler G, Meng F, Bui A, Kangarloo H. PMID: 18604762.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    149. 3-T contrast-enhanced MR angiography in evaluation of suspected intracranial aneurysm: comparison with MDCT angiography. AJR Am J Roentgenol. 2008 Feb; 190(2):389-95. Nael K, Villablanca JP, Mossaz L, Pope W, Juncosa A, Laub G, Finn JP. PMID: 18212224.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    150. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. J Clin Oncol. 2007 Oct 20; 25(30):4714-21. Chen W, Delaloye S, Silverman DH, Geist C, Czernin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T. PMID: 17947718.
      View in: PubMed   Mentions: 154     Fields:    Translation:Humans
    151. Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2. Clin Cancer Res. 2007 May 01; 13(9):2592-8. Carlson MR, Pope WB, Horvath S, Braunstein JG, Nghiemphu P, Tso CL, Mellinghoff I, Lai A, Liau LM, Mischel PS, Dong J, Nelson SF, Cloughesy TF. PMID: 17473188.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    152. Supraaortic arteries: contrast-enhanced MR angiography at 3.0 T--highly accelerated parallel acquisition for improved spatial resolution over an extended field of view. Radiology. 2007 Feb; 242(2):600-9. Nael K, Villablanca JP, Pope WB, McNamara TO, Laub G, Finn JP. PMID: 17255428.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    153. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006 Jun; 47(6):904-11. Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T. PMID: 16741298.
      View in: PubMed   Mentions: 173     Fields:    Translation:Humans
    154. MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology. 2006 Apr 25; 66(8):1258-60. Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF. PMID: 16636248.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    155. High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla. Invest Radiol. 2006 Apr; 41(4):391-9. Nael K, Ruehm SG, Michaely HJ, Pope W, Laub G, Finn JP, Villablanca JP. PMID: 16523022.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    156. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005 Nov-Dec; 26(10):2466-74. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. PMID: 16286386; PMCID: PMC7976216.
      View in: PubMed   Mentions: 228     Fields:    Translation:Humans
    Whitney's Networks
    Concepts (356)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (69)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-23-g6a590cb1 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California